ACTRN12610000958088已完成未知
Chronic hepatitis C patients - treated with either Spirulina platensis or Silymarin capsules - study for virological response, alanine aminotransferase enzyme, chronic liver disease questionnaire score for health related quality of life and Arizona sexual experience scale for sexual functions.
Abbass Helmy Charity0 个研究点目标入组 60 人开始时间: 2010年11月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •Chronic HCV genotype 4 diagnosis
- •HCV RNA positive with or without elevated liver enzymes
排除标准
- •Active schistosomiasis
- •Critically ill
研究者
相似试验
已完成
2 期
A pilot phase II open-label study of oglufanide disodium in patients with chronic hepatitis CChronic hepatitis CInfection - Other infectious diseasesACTRN12607000418471Implicit Bioscience Pty Ltd17
已完成
2 期
THE HEP573 STUDY: A randomised, double-blind, placebo-controlled clinical trial of silymarin alone, and silymarin combined with antioxidants in chronic hepatitis CChronic Hepatitis CAlternative and Complementary Medicine - Herbal remediesAlternative and Complementary Medicine - Other alternative and complementary medicineOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12614000966695John Hunter Hospital216
已完成
不适用
TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (HCC) USING PEG-INTERFERON ALPHA 2B AND RIBAVIRINEPER-039-01SCHERING PLOUGH RESEARCH INSTITUTE,
已完成
不适用
Retreatment of hepatitis C non-responsive to Interferon: a placebo controlled randomised trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the BeneluxChronic hepatitis CInfections and InfestationsHepatitisISRCTN53821378Schering Plough International (USA)117
进行中（未招募）
不适用
Tailoring antiviral therapy of chronic hepatitis C to the single patient standard therapy versus treatment guided by a physic-mathematical model of the dynamics of Hepatitis C Virus infection. - Tailoring antiviral therapy by HCV dynamicsChronic Hepatitis C with or without cirrhosisMedDRA version: 6.1Level: PTClassification code 10019744EUCTR2006-002483-26-ITAZIENDA OSPEDALIERA PISANA240